The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
The research report provides an in-depth evaluation of the Global Women’s Health Market and helps the market participants intensify their footprints in the industry. The report gives a detailed analysis concentrated on the critical market dynamics such as drivers, restraints, trends, and growth opportunities to assist businesses to prepare for any challenges they might encounter in the forecast period.
Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/91
Key questions answered in the report
- What will be the market size in terms of value and volume in the next five years?
- Which segment is currently leading the market?
- In which region will the market find its highest growth?
- Which players will take the lead in the market?
- What are the key drivers and restraints of the market’s growth?
The report also discusses the key players involved in the market such as:
Key participants include Merck & Co., Allergan, Bayer AG, Novartis AG, Pfizer, Amgen, Lupin Limited, Johnson & Johnson Services Inc., Agile Therapeutics, and Apothecus Pharmaceutical Corporation, among others.
Some Key Highlights from the Report
- By product type, devices held a substantial women’s health market share in 2019. The introduction of minimally invasive methods has escalated the demand for several surgical procedures amid the women population. Also, a growing trend among female patients’ towards technologically advanced techniques for treatment is the causative of market growth.
- By application, hormonal infertility is projected to grow at the fastest rate of 13.6% in the forecast period. High levels of FSH (follicle-stimulating hormone) in female blood may decrease the chances of conceiving. Also, abnormal estradiol, a kind of estrogen hormone, levels may reduce the possibility of success in vitro fertilization (IVF).
- By end-users, research institutes are projected to grow at the fastest rate in the forecast period. Various research institutes such as the Women’s Health Research Institute (WHRI) undertake several research activities to improve the health of women, especially reproductive health. Academic research institutes carry out many R&D activities to develop novel drugs and devices, which would fuel the market growth in the upcoming years.
- The women’s health market in the North America American region, in terms of revenue, contributed to the largest market share in 2019, attributed to the growing prevalence of women-related diseases aimed at enhancing the quality of life on promoting wellbeing and safety.
To know more about the report @ https://www.emergenresearch.com/industry-report/womens-health-market
Women’s Health Market segmentation:
Emergen Research has segmented the global women’s health market on the basis of product type, application, end-users, and region:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Devices
- Drugs
Application Outlook (Revenue, USD Billion; 2017-2027)
- Contraceptives
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Menopause
- Endometriosis
- Polycystic Ovary Syndrome (PCOS)
- Others
End Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals & Clinics
- Obstetrics & Gynecology Centers
- Ambulatory Surgical Centers
- Research Institutes
- Others
Regional Outlook: (Revenue, USD Billion; 2018-2028)
- North America (U.S.) (Canada) (Mexico)
- Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)
- Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)
- Latin America (Brazil) (Rest of LATAM)
Click here to Get customization @ https://www.emergenresearch.com/request-for-customization/91
Table of Contents:
- Chapter 1 includes an introduction of the global Women’s Health Market, along with a comprehensive market overview, market scope, product offerings, and an investigation of the market drivers, growth opportunities, risks, restraints, and other vital factors.
- Chapter 2 offers an in-depth analysis of the key manufacturers engaged in this business vertical, along with their sales and revenue estimations.
- Chapter 3 elaborates on the highly competitive terrain of the market, highlighting the key manufacturers and vendors.
- In Chapter 4, our team has fragmented the Women’s Health market on the basis of regions, underscoring the sales, revenue, and market share of each region over the forecast timeline.
- Chapters 5 and 6 have laid emphasis on the Women’s Health market segmentation based on product type and application Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-advanced-metering-infrastructure-market
